Literature DB >> 20620598

Distribution of common genetic subgroups in childhood acute lymphoblastic leukemia in four developing countries.

Rubina Siddiqui1, Nirmala Nancy, Win P Naing, Sarah Ali, Lalit Dar, Baldip K Khan, Rose A Padua, Robert Carr.   

Abstract

An international project was conducted to identify the common acute lymphoblastic leukemia (ALL)-specific fusion genes (ETV6-RUNX1,MLL-AF4,TCF3-PBX1, and BCR-ABL1) in developing countries to provide additional prognostic information at diagnosis. A total of 181 children with newly diagnosed ALL were tested by reverse transcriptase-polymerase chain reaction at laboratories in India, Pakistan, Myanmar, and Sudan, following a common protocol. To our knowledge, this report is novel in its report from these countries, except India. Across the four countries, the ETV6-RUNX1 (TEL-AML1) fusion gene was present in only 5% of cases. All the positive samples were from children aged 1 to 10 years, in whom the prevalence of this fusion gene, which is associated with good prognosis, was 7.4% (9 out of 121 samples), a much lower rate than reported from Western populations. In the 18 ALL cases tested in Sudan, a notable excess of MLL-AF4 (17%) and BCR-ABL1 (22%) fusion genes was found. This study highlights the need for wider international surveys of the molecular epidemiology of ALL. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620598     DOI: 10.1016/j.cancergencyto.2010.04.010

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  1 in total

1.  High frequency and poor prognosis of late childhood BCR-ABL-positive and MLL-AF4-positive ALL define the need for advanced molecular diagnostics and improved therapeutic strategies in pediatric B-ALL in Pakistan.

Authors:  Zafar Iqbal; Tanveer Akhtar; Tashfin Awan; Aamer Aleem; Noreen Sabir; Mahmood Rasool; Muhammad Absar; Afia M Akram; Masood A Shammas; Ijaz H Shah; Muhammad Khalid; Abid S Taj; Abid Jameel; Abdullah Alanazi; Ammara T Gill; Jamil Amjad Hashmi; Akhtar Hussain; Muhammad Farooq Sabar; Ahmad M Khalid; Mehmood Hussain Qazi; Sajjad Karim; Muhammad Hassan Siddiqi; Aamir Mahmood; Mudassar Iqbal; Anjum Saeed; Muhammad Imran Irfan
Journal:  Mol Diagn Ther       Date:  2015-10       Impact factor: 4.074

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.